Search companies or stocks...
BMEABiomea Fusion, Inc.
At close · 02 Sept 2026, 08:00 pm
Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.
Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers…
Current stock price of Biomea Fusion, Inc. (BMEA) stock is $1.940. The stock price is +7.50% higher in the session. The intraday range can be seen from this page. Volume of Biomea Fusion, Inc. (BMEA) stock is 2.12M.
Last updated at 02 Sept 2026, 08:00 pm.
The stock price of Biomea Fusion, Inc. (BMEA) can change with earnings, company news, and overall market sentiment. Biomea Fusion, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.
Whether Biomea Fusion, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for BMEA on this page is -1.61. EPS on this page is -1.20. Compare those figures with peers and growth expectations before deciding if the current Biomea Fusion, Inc. price is justified.
Historical performance for Biomea Fusion, Inc. (BMEA) is shown on the price chart on this page. Review multi-period moves alongside volume to see how BMEA reacted to past earnings and market events.
Buying Biomea Fusion, Inc. (BMEA) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.
